Suppr超能文献

相似文献

1
Macrolides: From Toxins to Therapeutics.
Toxins (Basel). 2021 May 12;13(5):347. doi: 10.3390/toxins13050347.
2
Structures of microfilament destabilizing toxins bound to actin provide insight into toxin design and activity.
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14527-32. doi: 10.1073/pnas.0502089102. Epub 2005 Sep 28.
4
Therapeutic potential of marine macrolides: An overview from 1990 to 2022.
Chem Biol Interact. 2022 Sep 25;365:110072. doi: 10.1016/j.cbi.2022.110072. Epub 2022 Aug 8.
5
Use of the F-actin-binding drugs, misakinolide A and swinholide A.
Methods Enzymol. 1998;298:26-32. doi: 10.1016/s0076-6879(98)98005-3.
6
Biselyngbyaside, a macrolide glycoside from the marine cyanobacterium Lyngbya sp.
Org Lett. 2009 Jun 4;11(11):2421-4. doi: 10.1021/ol900579k.
7
Marine Macrolides with Antibacterial and/or Antifungal Activity.
Mar Drugs. 2019 Apr 23;17(4):241. doi: 10.3390/md17040241.
8
The macrolide antibiotic renaissance.
Br J Pharmacol. 2017 Sep;174(18):2967-2983. doi: 10.1111/bph.13936. Epub 2017 Aug 10.
9
Actin-depolymerizing effect of dimeric macrolides, bistheonellide A and swinholide A.
J Biochem. 1998 Apr;123(4):571-8. doi: 10.1093/oxfordjournals.jbchem.a021975.
10
New anti-actin drugs in the study of the organization and function of the actin cytoskeleton.
Microsc Res Tech. 1999 Oct 1;47(1):18-37. doi: 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E.

引用本文的文献

1
An intriguing case of macrolides-induced pancreatic injury mimicking pancreatic carcinoma.
Hepatobiliary Surg Nutr. 2025 Aug 1;14(4):720-723. doi: 10.21037/hbsn-2025-269. Epub 2025 Jul 25.
2
: Epidemiology and resistance evolution of an emerging zoonotic bacteria.
One Health. 2025 Jun 16;21:101098. doi: 10.1016/j.onehlt.2025.101098. eCollection 2025 Dec.
3
Clarithromycin-Loaded Albumin-Based Nanoparticles for Improved Antibacterial and Anticancer Performance.
Pharmaceutics. 2025 May 31;17(6):729. doi: 10.3390/pharmaceutics17060729.
4
Novel Tetraene Macrodiolides Are Effective Inducers of Mitochondrial Apoptosis in Jurkat Cells.
Int J Mol Sci. 2025 May 27;26(11):5139. doi: 10.3390/ijms26115139.
5
The divergent intron-containing actin in sponge morphogenetic processes.
NAR Genom Bioinform. 2025 Jun 4;7(2):lqaf071. doi: 10.1093/nargab/lqaf071. eCollection 2025 Jun.
8
A mechanistic overview on green assisted formulation of nanocomposites and their multifunctional role in biomedical applications.
Heliyon. 2025 Jan 8;11(3):e41654. doi: 10.1016/j.heliyon.2025.e41654. eCollection 2025 Feb 15.

本文引用的文献

1
Marine-Derived Macrolides 1990-2020: An Overview of Chemical and Biological Diversity.
Mar Drugs. 2021 Mar 25;19(4):180. doi: 10.3390/md19040180.
2
Use of ivermectin in the treatment of Covid-19: A pilot trial.
Toxicol Rep. 2021;8:505-510. doi: 10.1016/j.toxrep.2021.03.003. Epub 2021 Mar 9.
3
Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action.
Naunyn Schmiedebergs Arch Pharmacol. 2020 Jul;393(7):1153-1156. doi: 10.1007/s00210-020-01902-5. Epub 2020 May 27.
5
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
6
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer.
Antiviral Res. 2020 May;177:104760. doi: 10.1016/j.antiviral.2020.104760. Epub 2020 Mar 3.
7
Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical Applications.
Chemistry. 2020 Jan 27;26(6):1166-1195. doi: 10.1002/chem.201903128. Epub 2019 Nov 19.
8
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B.
Clin Infect Dis. 2019 May 2;68(Suppl 4):S260-S274. doi: 10.1093/cid/ciz076.
9
Adverse events in people taking macrolide antibiotics versus placebo for any indication.
Cochrane Database Syst Rev. 2019 Jan 18;1(1):CD011825. doi: 10.1002/14651858.CD011825.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验